Showing results for "#Aurobindo"

Pharma Industry growth will be driven by domestic formulations and...

Alongside this revenue growth, EBITDA is projected to rise by 10.5 per cent YoY and 3.8 per cent QoQ, with adjusted Profit After Tax (PAT) expected to...